Skip to main content
. 2020 Oct 21;10:17353. doi: 10.1038/s41598-020-74078-w

Table 1.

Population characteristics.

Characteristic Preeclampsia
(N = 23)
Controls
(N = 50)
p valuea
Median (IQR) or N (%) Median (IQR) or N (%)
Maternal age 32.3 (28.1–36.6) 31.3(26.2–36.9) 0.63
Maternal race 0.74
 Black 6 (26.0%) 14 (28.0%)
 Hispanic 2 (8.7%) 10 (20.0%)
 White, non-Hispanic 15 (65.2%) 26 (52.0%)
Nullipara 5 (22.0%) 14 (28.0%) 0.42
Smoking 4 (17.4%) 10 (20.0%) 0.79
Married 16 (70.0%) 31 (62.0%) 0.89
Chronic hypertension 3 (13.0%) 0 (0.0%) 0.009
Chronic renal disease/proteinuria 0 (0.0%) 0 (0.0%) NA
Pre pregnancy BMI 24.6 (21.1–29.1) 25.5 (22.5–30.0) 0.74
PE in prior pregnancy 6 (33.3%) 3 (8.3%) 0.02
Prior spontaneous PTB 12 (66.7%) 8 (22.2%) 0.001
Gestational age (weeks) at
 Sampling 11.3 (8.7–13.4) 11.1 (9.6–13.7) 0.97
 Delivery 34.4 (32.0–35.3) 39.4 (38.9–40.4) < 0.001
Birth metrics (g)
 Birth weight 2215 (1400–2811) 3353 (3140–3725) < 0.001
 Z-score − 0.24 (− 1.1–0.6) − 0.21 (− 0.7–0.8) 0.45
Infant gender
 Female 15 (65.2%) 26 (52.0%) 0.29
 Male 8 (34.8%) 24 (48.0%)
Clinical characteristics
 Median maximum systolic (mmHg) 168 (147–180) 112 (103–120) < 0.001
 Median maximum diastolic (mmHg) 96 (88–99) 68 (61–73) < 0.001
 Median 24 h protein (gram) 581 (343–921) NA NA
 Week of PE diagnosis 32.4 (29.7–33.0) NA NA

ap values calculated with Wilcoxon Rank Sum test, ANOVA, Chi Square test, or Fisher Exact test where appropriate.

NA not applicable/available.